Lantern Pharma Inc.

NASDAQ:LTRN

3.42 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -15.962-14.26-12.363-5.908-2.428-1.726
Depreciation & Amortization 0.1750.010.0070.0030.002-0.003
Deferred Income Tax -1.81300.113-1.0820.2520
Stock Based Compensation 1.0681.1880.9621.1920.1180.186
Change In Working Capital 0.538-0.6120.6-0.9390.1810.272
Accounts Receivables -0.159-0.158-0.072000.187
Inventory 000000
Accounts Payables -0.2360.581.6220.1170.3730.07
Other Working Capital 0.933-1.034-0.95-1.056-0.1920.272
Other Non Cash Items 1.6470.9060.0911.082-0.252-0.076
Operating Cash Flow -14.347-12.767-10.592-5.652-2.128-1.272
Investing Activities:
Investments In Property Plant And Equipment -0.019-0.028-0.015-0.016-0.0060
Acquisitions Net 930.21-179.26819,530.586000.005
Purchases Of Investments -8.196-3.913-19.579000
Sales Maturities Of Investments 7.2854.120.064000
Other Investing Activites -930.21179.268-19,530.586-5.71700.005
Investing Cash Flow -0.930.179-19.531-0.016-0.0060.005
Financing Activities:
Debt Repayment 000-0.16900
Common Stock Issued 00.36923.5572.9210
Common Stock Repurchased -0.5-0.002-0.94000
Dividends Paid 000000
Other Financing Activities -499.9970-4.6440.2770.0030.535
Financing Cash Flow -0.5-0.00263.41623.6652.9210.535
Other Information:
Effect Of Forex Changes On Cash -0.028-0.0110.001000
Net Change In Cash -15.805-14.78133.29517.9970.787-0.731
Cash At End Of Period 21.93837.74352.52419.2291.2320.445